SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Medical Industries Of America, MIOA

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TradeOfTheDay who wrote (190)6/11/1997 1:13:00 PM
From: Mr. Miller   of 570
 
Madame Smith:
Point well taken, so clarification of words are in order. With MIOA being the only JACO accredited mobile catheterization company, I deduced that MCTH is not JACO accredited for this service. Is this not reasonable?
Back to MIOA. It is the fundamentals of a company-especially a small company, that will keep it around long term. Along the ascent, much fluctuation will provide profits for the quick in and outers. Nothing wrong with that at all. Shorts are players too, so why blast them. Sure, they screw around with our stock, but so do PR firms, and threads like these, with hyping talk and hope for big gains. The bottom line is luck for shorters and the in and outers. We who choose to watch that game can laugh and wait for time to allow MIOA to grow. Companies don't sprout up overnight like that vine in Jack and the beanstock. I wonder how many of us play some of those games now. And if you do, I still respect your willingness to get in the stock market at all. It is truly the best way to expanding wealth-a fact that many are afraid or unwilling to grasp. I am young and looking forward to a long life of winning and losing(hopefully alot more wins).
Jones, I am sure you will read this as diligent as you are at critiquing. You state impressive objectives and are actively involved. (Not that you need me to tell you). I have enjoyed reading your comments, along with those for other threads-this can be as good as research on a company. Credibility goes along way.
I have been molded into a skeptic in many ways due to a serious background in biological research. However, I like the risks, as long as it is extra beyond solid foundational investments. So, yeah, I got some MIOA, and I am here to stay, as long as Mr. Morrell hangs. I do not know him but from phone conversations. When you guys meet him later this month, please report back to those of us who will be unable to attend, about what he is like in person. Fluff or realistic?
There are many companies with a product to sell out there like AUXI, but who will buy that stuff, few buy slick 50 now and most mechanics tell you it is garbage. MIOA has not a new product, but a fresh start. It is too bad for those of you who were hurt by the reverse split, but if you are still around-smart move. When I said that this was like a company that just went public, it is from the perspective that there are all new players in management(including today's news), there are few shares, there was nowhere to go but up, and it is from revenues and profits point of view(at least less negative). The bad bad bad thing is we have a history, you can never lose that, and over $18 million in the hole. Forget about the past, you can't change that. Yeah, they could fail, but it would be this management team's first failure, not second. What happened before was not their fault. There was a solid product and that group did not grasp the opportunity well. This team is-we made more revenues last quarter than the previous team did in, what, 5 quarters?.
MCTH picked up the idea and has run all the way to the bank with it (since 1992; MIOA was established in 1989)even though its mobile labs have not received accreditaion to my knowledge; yet, they traded at levels above $40 before they fumbled the ball and went long on for-profit hospitals. Maybe they will succeed, but they are not concentrating on mobile labs as they did for years to get them to over$40. This is good for us. Go MIOA GO GO GO!
No hype, just hope for the management to get out there and hook 'em. This is my angle. The rest of you can dissect bean counters pages and present good stuff to us. Although I do care about revenues , net profits, and growth.
My concerns are that we have not added new physicians in over 5 months, when it was said that so many were interested(over 100). Cath lab 3 was supposed to be at FPII in March, but it just got there. And where is cath lab four? That was supposed to be at FPII in April. Then you hear about selling cath labs. To who? MCTH? Just kidding. Ten by next year. Yeah three for us and 7 sold to MCTH fully functioning. Ha ha. Stop shuffling the management deck and get down to the deal making. I can applaud the two fixed sites with Vitacare. Good job, but did it take you 5 months to do just that. If so, we are in for very slow growth. Where is all the demand for MIOA? This is what I am saying. They just have to contact everyone and sell the concept, not the product.
If they did nothing else for two years-nothing- they could probably turn 30-50 cents per annum and hit levels of 5-10 dollars. But growth, ah, that will drive the stock upward, not one quarter of small profits based on shares outstanding that we will probably and hopefully never see again(referring to another reverse split) If you add 200,000 in profits per quarter, you can add 1 million shares and still maintain .20 eps. It is just that you need probably 1million in quarterly revenues to have 200,000 in profits.
Let's hope that this quarter will be profitable in double digit eps, but I think that audited annual revenues next year will be the time that this stock moves to high levels(above $8.00). In the meantime good luck shorts(I hate you but you are there), good luck in and outers(you will make money), and thank you long term holders.


Look forward to conversing with you in the future.

Miller
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext